Nuovo Pharmaceuticals Private Limited
About Nuovo Pharmaceuticals Private Limited
Data last updated:
Nuovo Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 21 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2019PTC319953.
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹30,000. It is led by directors including Shahnawaz Ali Syed and Abdul Sirajuddin Wahid.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at 301 Floor 3rd Plot – 285/289 Suleman Tower Parshuram Pupala Marg Kamathipura, Mumbai, Maharashtra, India – 400008.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nuovo Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.
- Registered Address301 Floor 3rd Plot – 285/289 Suleman Tower Parshuram Pupala Marg Kamathipura, Mumbai, Maharashtra, India – 400008
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nuovo Pharmaceuticals Private Limited
FY 2019 filings availableFinancial Statement Summary
| Metrics | FY 2018-19 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2018-19 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Nuovo Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nuovo Pharmaceuticals Private Limited
Nuovo Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shahnawaz Ali Syed | Director | 21 Jan 2019 | 7 Years 9 Months | Current |
| Abdul Sirajuddin Wahid | Director | 21 Jan 2019 | 7 Years 9 Months | Current |
| Mohammed Shadab Salim Khan | Director | 21 Jan 2019 | 7 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Nuovo Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nuovo Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nuovo Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nuovo Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Abdul Sirajuddin Wahid was appointed as Director on 21 Jan 2019.
Frequently asked questions
Nuovo Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 21 January 2019 (7+ years old) and is registered under CIN U24230MH2019PTC319953.
Nuovo Pharmaceuticals has 3 current directors:
- Shahnawaz Ali Syed - Director
- Abdul Sirajuddin Wahid - Director
- Mohammed Shadab Salim Khan - Director
The latest financial statements of Nuovo Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Nuovo Pharmaceuticals is U24230MH2019PTC319953. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nuovo Pharmaceuticals was incorporated on 21 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Abdul Sirajuddin Wahid was appointed as Director on 21 Jan 2019. Mohammed Shadab Salim Khan was appointed as Director on 21 Jan 2019. Shahnawaz Ali Syed was appointed as Director on 21 Jan 2019.
The registered office of Nuovo Pharmaceuticals is at 301 Floor 3rd Plot – 285289 Suleman Tower Parshuram Pupala Marg Kamathipura, Mumbai, Maharashtra, India – 400008.
Nuovo Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Nuovo Pharmaceuticals is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.
Nuovo Pharmaceuticals can be reached at its registered office: 301 Floor 3rd Plot – 285289 Suleman Tower Parshuram Pupala Marg Kamathipura, Mumbai, Maharashtra, India – 400008.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
